NCT01986062View on ClinicalTrials.gov

Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting

PHASE4CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Attention Deficit Hyperactivity Disorder (ADHD)
Interventions
DRUG

AR11

DRUG

Placebo

Trial Locations (7)

27705

Duke University Medical Center, Durham

32751

Florida Clinical Research Center, LLC, Maitland

33143

Miami Research Associates, South Miami

34201

Florida Clinical Research Center, LLC., Bradenton

77007

Bayou City Research Ltd., Houston

79423

Westex Clinical Investigations, Houston

89128

Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas

Sponsors
All Listed Sponsors
lead

Arbor Pharmaceuticals, Inc.

INDUSTRY

NCT01986062 - Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting | Biotech Hunter | Biotech Hunter